NFKB1 and osteosarcoma: This assertion is based on several observations: (1) GLP2 inhibits the expression and activity of inflammation-related gene NF-κB in osteosarcoma cells, and (2) excessive NF-κB fully abrogates the function of cancerous suppression of GLP2 in osteosarcoma cells.